7th Annual Diversity, Inclusion, & Life Sciences Symposium
LEADING SYMPOSIUM DISCUSSING DIVERSITY IN THE HEALTH SECTOR
Chicago, IL, USA
Chicago, IL, USA
The 7th annual Diversity, Inclusion, & Life Sciences Symposium is the leading annual, collaborative symposium for health sector professionals and executives, physicians, HR professionals, clinical trial professionals and patients, entrepreneurs, patient groups, researchers, academics, and diversity and inclusion advocates to discuss diversity and inclusion in the life sciences and the health sector. The symposium focuses specifically on the latest trends, challenges, opportunities, and best practices of implementing strategies and tactics to make these industries more diverse and inclusive, as well as understand how to better serve different patient groups. Attendees will learn the newest insights and ideas, discuss practical solutions, and meet industry and marketplace colleagues.
the world’s #1 symposium focusing specifically on the interface of diversity, inclusion, and the health sector
the obstacles to clinical trials and healthcare access for underrepresented patient populations
knowledge regarding why coaching and mentoring are vital to workforce development
on building an organizational culture that attracts the best and brightest people, resulting in a diverse and productive workforce
how diversity and inclusion drive innovation and new thinking within organizations
a workplace that embraces and promotes an inclusive environment by leveraging the latest D&I trends and ideas
best practices for recruiting, retaining , and promoting a diverse workforce
and share ideas with many of the country’s leading health sector professionals who are passionate about diversity and inclusion
Rush University Medical Center
Dr. Neelum Aggarwal, MD, is a population health neurologist at Rush and clinical researcher in the field of longevity and aging. She is co-leader of the federally funded Rush Alzheimer’s Disease Center Clinical Core in Chicago and an associate professor in the Department of Neurological Sciences at Rush University Medical Center. Dr. Aggarwal is the co-principal investigator for the federally funded PCORI grant, Community Engagement for Early Recognition and Immediate Action in Stroke (CEERIAS) study, which is a multi-institutional and academic-community partnered program designed to address disparities in stroke awareness, barriers to health care access, and treatments and outcomes in Chicago’s minority communities. She is the first chief diversity officer for the American Medical Women’s Association – the oldest women’s physician medical organization in the United States – and is responsible for defining national diversity and inclusion objectives, enhancing the diversity of AMWA’s leadership team, and leading AMWA’s Diversity and Inclusion Section and resource groups.
Dr. Paul Underwood, MD, FACC, FSCAI is a medical director for the interventional cardiology/structural heart franchise at Boston Scientific and a member of Close the Gap, Boston Scientific’s health equity education initiative. At Boston Scientific, Dr. Underwood recently received the Interventional Cardiology Business Unit Diversity Award for his work with the PLATINUM Diversity trial, the first interventional cardiology study to focus solely on women and minorities. In 2015 he also received the Chairperson’s Award from the National Forum for Heart Disease and Stroke Prevention. Prior to Boston Scientific, Dr. Underwood practiced interventional cardiology and clinical research in Phoenix for over 18 years and has been actively involved in community-based efforts focused on promoting cardiovascular health. He received his MD degree from the Mayo Clinic, followed by a cardiology fellowship at the Cleveland Clinic.
Dr. Khaudeja Bano, MD, is a physician with a Masters in Clinical Research (UCSD), Oracle DBA, PMP and Pharmaceutical engineering Certification. She is an Abbott President’s award winner, avid Toastmaster, and certified coach. Dr. Bano has more than 25 years professional experience, including clinical practice. She has held several global safety positions at Abbott Vascular, Abbott Diagnostics, Abbott Established Pharma Division, and now AbbVie. Her career in safety includes leadership roles in devices, diagnostics, pharmaceuticals and combination products. She has a diverse background in Medical Affairs, Device Safety, Pharmacovigilance, Risk management, Clinical Research / operations, Project management, Quality and Information Systems including extensive Global experience. Dr. Bano is passionate about D&I issues for the life sciences.
Dr. Daniel J. Smith, PhD, MBA, is Leader of Data Quality and Analytics at Mercy Health. Dr. Smith also serves as an Adjunct Professor of Applied Research at multiple institutions. He is a leader in research and analytics who understands the challenges of leaders in regard to creating and sustaining the capabilities for data-driven decision making and relating to their constituents, from frontline employees to senior-level executives. Dr. Smith draws on his cross-industry experience to help leaders optimize their performance through creative problem solving to generate strategic organizational insights. Prior to Mercy Health, Dr. Smith served as a Senior Analyst at Banner Health. Dr. Smith earned his Ph.D. and MBA from Arizona State University. In addition, Dr. Smith holds his B.A. from Whitman College, and earned his M.A. from Middlebury College.
Dr. Leon Rozen is the Vice President Head Global Immunology Medical Affairs at Shire. Leon has over 20 years management and leadership experience in the health sector, pharmaceutical and biotech industries. He has worked in management positions in Australia and Europe during which time he led strategy development, set up teams and functions and led major international projects for a multinational company. He is a Fellow of the Royal College of Pathologists of Australasia and an Associate Fellow of the Royal Australasian College of Medical Administrators. Prior to join Shire, he is a Senior Medical Director at Baxalta. He has received accreditation as a practitioner of Extended DISC personality profiling and Neurolinguistic Programming (NLP) and is a certified Performance Coach.
Dr. Jorge A. Caballero, MD, is the CEO of Distal, a company that offers SaaS products that uniquely transform existing data into actionable insights that empower health care providers to deliver better care. He is an accomplished product and business leader with 10+ years of experience developing innovative health care solutions. Dr. Caballero also serves as Clinical Instructor of Anesthesiology, Perioperative and Pain Medicine at Stanford University School of Medicine. Prior to founding Distal, Jorge worked at Amino where he led data product innovation, and recruited the data science team. He has contributed to the finding of a new treatment for patients with metastatic cancer. Dr. Caballero holds his B.A. in Chemistry with a minor in Biological and earned a MD from Stanford University.
GMAx Consulting, LLC
Mr. Jose F. Gomez is President and Founder of GMAx Consulting, LLC, providing specialized market access advisory and business strategy consulting services to the biopharmaceuticals industry and healthcare investment community. Prior to GMAx Consulting, Mr. Gomez was Global VP and Head, Global Market Access, Pricing and Reimbursement Center of Excellence at Shire. Prior to Shire, Mr. Gomez held various leadership roles of increasing responsibility in pricing, access, global marketing, business development and finance at Abbott, Eli Lilly and PWC. Mr. Gomez is currently Vice Chair of the National Hispanic Life Sciences Society, holds an MBA from Indiana University Kelley School of Business and is a Consortium for Graduate Study in Management Alumni. He is a CPA, CFM and CMA.
Ms. Almenia Garvey, MS, is Director, Health Care Alliances at ICON Plc. With over 20 years of clinical research experience, she is a strong leader and proven relationship builder. Almenia is a site relations expert who specializes in minority recruitment, site selection strategy, investigator identification and investigator relationship management. ICON plc is a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries. Her prior role was Associate Director, Site Alliances at PAREXEL. Her education includes a M.Sc., Communication, Advertisement and Public Relations from Ulster University.
Bridge Clinical Research
Dr. Owen Garrick, MD, MBA, is President & COO of Bridge Clinical Research. Bridge Clinical is a global patient recruitment healthcare communications company. It is also the leading company focused on increasing the participation of minority investigators and patients in clinical trials. Dr. Garrick was formerly Director of Corporate Strategy and M&A at McKesson. Prior to McKesson, Dr. Garrick was Global Head of M&A Negotiations at Novartis. Previously he was at Goldman Sachs in New York. Dr. Garrick earned his MD from Yale, MBA from Wharton. He holds an AB from Princeton University. Dr. Garrick also serves on the boards of Sutter Health, the American Psychiatric Association Foundation and Samuel Merritt University. He was confirmed to the HHS Secretary’s Advisory Committee on Human Research Protections in 2012.
Dr. Shailja Dixit, MD, MPH/MBA, MS, is Executive Director of Medical Affairs at Allergan. She is an accomplished healthcare and pharmaceutical physician executive with more than 15 years of healthcare industry experience with Big Pharma (Sanofi and Pfizer), Big-5 Consulting (Accenture), Payer (Aetna) and Provider Groups. Dr. Dixit has a global perspective gained from roles in the US, Europe and Asia-Pacific in variety of areas: Big Pharma Experience in elderly population portfolio (Alzheimer’s, pain, osteoarthritis, hearing disorder), metabolic (diabetes), cardiovascular (lipid lowering) and neutraceuticals; Experience in Device, Drug value and evidence development for a successful launch & optimum access in Global Markets; and Experience in Health Outcomes and Health Economics methodologies and models.
Dr. Scott Treiber, PhD, MBA, is Executive Vice President, Biopharmaceutical Development & GM at Chiltern. He is an experienced professional with over 20 years of increasing responsibility in the biopharmaceutical and device industry. Dr. Treiber has expertise in clinical operations, clinical development, medical affairs, data management/statistics, pharmacovigilance/safety and medical writing. He also has broad therapeutic expertise in CNS, oncology, hematology, pain, cardiovascular, renal, anti-infectives, and respiratory. Dr. Treiber also has experience with managed budgets (>$100M), resources, metrics and quality systems. His prior roles include Senior Vice President & General Manager, Neuroscience at inVentiv Health Clinical; and VP, Global Clinical Operations & Medical Affairs at Hospira.
University of Chicago Medical Center
Ms. Brenda Battle, MBA, BSN, RN, serves as The University of Chicago Medical Center’s Vice President for Care Delivery Innovation and Chief Diversity and Inclusion Officer. She is responsible for leading UCMC’s transformation to population health management, implementing new models of care and integrating care between the hospital and community. Battle’s prior experience includes serving as the director of the Center for Diversity and Cultural Competence for Barnes-Jewish Hospital on the Washington University Medical Center Campus, St. Louis, MO. She served as a health care lobbyist for several years and held several leadership roles in the managed care industry.
The Kaleidoscope Group
Mr. Doug Harris is the Chief Executive Officer of The Kaleidoscope Group with almost 30 years of experience in the field of diversity & inclusion consulting. Prior to joining Bea Young Associates in 1993, Doug worked for several years as a consultant and trainer for Harbridge House, Inc. where he facilitated diversity & inclusion education sessions with senior executives of Fortune 500 organizations. Today, as the leader of The Kaleidoscope Group, Doug empowers organizations to achieve their diversity and inclusion goals. His knowledge and expertise guides organizations through the creation of customized strategies that address the specific diversity needs of the business. He recently developed and launched The Kaleidoscope Group Youth Practice to assist underserved youth in the Chicagoland and surrounding communities and is working with Tufts University to design and implement a student leadership development program.
American Medical Association
Ms. Leslie M. Stokes, MBA, is the Senior Vice President of Physician Engagement at the American Medical Association. She is the executive sponsor of a Diversity Initiative that launched in 2015. Prior to AMA, Leslie spent more than 20 years of combined sales and marketing experiences at Merck, Johnson & Johnson and Baxter Healthcare. During her time at Baxter, she worked in Global Marketing and was also the Co-President of the African-American Leadership Council, a newly formed business resource group. Leslie holds a BS in Business Administration and Marketing from Penn State University and an MBA in International Business from Temple University. Leslie lives in downtown Chicago and in her spare time enjoys mentoring early career professionals.
Ms. Dima Elissa, MBA, is the CEO and founder of VisMed-3D, a medical 3D printing company. She is also the Diversity, Inclusion, and Innovation (D & I2) – Tech & Innovation Lead at American Medical Women’s Association. As an adjunct faculty member teaching Entrepreneurship at the Associated Colleges of the Midwest in Chicago and in-demand speaker, she exemplifies her commitment to giving back and paying it forward. She currently serves on the boards of mHUB Chicago, BWG Strategy LLC, Ms. Tech, Women in Bio, Galvanize Labs, and is on the STEM steering committee for the Aparecio Foundation, which provides mentoring to high-achieving, low- income female high school students. Dima holds a B.A. in Chemistry from Hanover College, and earned her MBA from Texas A&M’s May’s School of Business with a concentration in Finance.
Healthcare Research Associates
Ms. Regina Greer-Smith, MPH, is a member of the Advisory Panel for Patient Engagement at the Patient Centered Outcomes Research Institute (PCORI). Regina is the President and Owner of Healthcare Research Associates, LLC. Regina’s work includes building and maintaining collaborations between communities and stakeholders that enable improved healthcare outcomes. Regina is a consultant /healthcare coordinator to agencies providing services to developmentally and intellectually disabled adults in Illinois and the use of mobile technology to enable collaboration between patients/caregivers and providers. She is the developer and principal investigator of The S.T.A.R. Initiative. The mission of The S.T.A.R. Initiative is to increase minority participation in patient-centered outcomes research and clinical trials. Regina holds a Master of Public Health Degree (MPH) from Benedictine University and is a Fellow with The American College of Healthcare Executives.
by Doug Harris11:15 AM
191 N. Wacker Drive | Suite 3700
Chicago, IL, USA 60606
Please contact us with any symposium questions.